About Concert Bio
Concert Bio is a company based in London (United Kingdom) founded in 2021 by Paul Rutten. Concert Bio has raised $1.7 million across 2 funding rounds from investors including The Venture Collective, Nucleus Capital and Ponderosa Ventures. The company has 3 employees as of June 30, 2023. Concert Bio offers products and services including Beneficial Microbes and Microbiome Monitoring Service. Concert Bio operates in a competitive market with competitors including Mosaic and Bioinfile, among others.
- Headquarter London, United Kingdom
- Employees 3 as on 30 Jun, 2023
- Founders Paul Rutten
-
Sectors
Healthcare
-
Email
Locked
-
Phone
Locked
-
Website
Locked
-
Social
Locked
- Legal Name Concert Bio Ltd
- Date of Incorporation 16 Aug, 2021
- Jurisdiction LONDON, ENGLAND
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Total Equity Funding
$1.7 M (USD)
in 2 rounds
-
Latest Funding Round
Not available
-
Investors
The Venture Collective
& 7 more
-
Employee Count
3
as on Jun 30, 2023
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Concert Bio
Concert Bio offers a comprehensive portfolio of products and services, including Beneficial Microbes and Microbiome Monitoring Service.
Products that improve crop yield and resilience in hydroponics
Service using DNA sequencing for pathogen detection and consultation
People of Concert Bio
Unlock access to complete
Unlock access to complete
Funding Insights of Concert Bio
Concert Bio has successfully raised a total of $1.7M across 2 strategic funding rounds. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
Investors in Concert Bio
Concert Bio has secured backing from 8 investors, including venture fund and institutional investors. Prominent investors backing the company include The Venture Collective, Nucleus Capital and Ponderosa Ventures.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Venture capital fund focused on multiple sectors
|
Locked | Locked | Locked | |
|
-
|
Locked | Locked | Locked | |
|
Early-stage venture capital firm investing in and supporting technology startups
|
Locked | Locked | Locked |
Investor details for Concert Bio
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Concert Bio
Investment portfolio details for Concert Bio
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - Concert Bio
Detailed financials for Concert Bio
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Concert Bio Comparisons
Peer comparison for Concert Bio
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Concert Bio
Concert Bio operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Mosaic and Bioinfile, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Crypto asset data and research are provided by the platform.
|
|
| Locked | Locked | Locked |
Provides specialized databases for daily bioinformatics use in laboratories.
|
Detailed competitors of Concert Bio
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Concert Bio
Complete news archive for Concert Bio
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Concert Bio
Concert Bio was founded in 2021 and raised its 1st funding round 1 year after it was founded.
Concert Bio is headquartered in London, United Kingdom. It is registered at London, England, United Kingdom.
Paul Rutten is the current CEO of Concert Bio. They have also founded this company.
Concert Bio is a funded company, having raised a total of $1.7M across 2 funding rounds to date.
As of Jun 30, 2023, the latest employee count at Concert Bio is 3.
Founded in 2021 and based in London, United Kingdom, Concert Bio operates in the biotech sector. A platform is offered to microbiome researchers for collaboration and research data sharing. Monitoring and analytical services are provided to support the development of interventions using beneficial microbiomes. Operations focus on fostering community-driven advancements in microbiome science.
Concert Bio offers Beneficial Microbes and Microbiome Monitoring Service.
Concert Bio has 8 investors. Key investors include The Venture Collective, Nucleus Capital, Ponderosa Ventures, Tet Ventures, and Day One Ventures.